Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety, Efficacy, & Pharmacokinetic Study of Tamibarotene to Treat Patients With Relapsed or Refractory APL (STAR-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00520208
Recruitment Status : Completed
First Posted : August 23, 2007
Last Update Posted : February 13, 2013
Sponsor:
Information provided by (Responsible Party):
CytRx

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2012
Actual Study Completion Date : January 2013